Abstract
The aim of the present work was, first, to clarify the question of which part of factor XIIa is formed in blood plasma by the reciprocal mechanism (reactions 1, 2); second, it was required to determine which of the two agents - factor XIIa inhibitor from corn or kallikrein inhibitor contrical - was more effective for inhibition of factor XII and precallikrein activation at the contact surface. A pool of platelet-poor citrate plasma obtained from donor blood was used in the experiments. In order to reduce contact activation of blood, fluoroplastic dishes and plastic dispensers were used when obtaining, processing, and storing it.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
